z-logo
open-access-imgOpen Access
Successful treatment of a chemo-resistant gestational trophoblastic neoplasia using GEMOX. Clinical case
Author(s) -
Andrey Meshcheryakov,
T. E. Tikhomirova,
L. A. Meshcheryakova
Publication year - 2020
Publication title -
russian journal of oncology
Language(s) - English
Resource type - Journals
eISSN - 2412-9119
pISSN - 1028-9984
DOI - 10.18821/1028-9984-2020-25-1-42-46
Subject(s) - gestational trophoblastic neoplasia , medicine , regimen , malignancy , chemotherapy , trophoblastic tumor , obstetrics , trophoblastic neoplasm , gynecology , gestation , pregnancy , biology , genetics
Gestational trophoblastic neoplasia is a rare malignancy. The main treatment approach is chemotherapy. Almost all patients can be cured if the diagnosis is established timely and adequate treatment is provided in specialized centers. In a small part of patients, the tumor progresses despite the use of all standard chemotherapy regimens. Treatment of such patients is difficult for all oncologists, including ones working in specialized centers for the treatment of gestational trophoblastic neoplasia. This article presents a clinical case of the successful treatment of a patient with multidrug resistant gestational trophoblastic neoplasia using GEMOX regimen.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom